skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Invasive Mycoses

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Invasive Mycoses

Member Financial Disclosure
Company Relationship
Ampel, Neil*
University of Arizona None N/A
Blair, Janis
Mayo Clinic Arizona
None N/A
Hage, Chadi
Indiana University
None N/A
Hamill, Richard
Baylor College of Medicine
None N/A
Kauffman, Carol
University of Michigan and VA Ann Arbor Healthcare System
New England Research Institutes Adjudication Panel for Resolving Infection in Neutropenia with Granulocytes Study
Pappas, Peter
University of Alabama at Birmingham
Astellas Advisory Board, Consulting, Honoraria, Research Support
Merck Advisory Board, Research Support, Speaker’s Bureau
Pfizer Advisory Board, Research Support
T-2 Diagnostics Advisory Board
Perfect, John
Duke University
Astellas Advisory Board, Consultant, Honoraria, Research Support
F2G Advisory Board, Consultant, Honoraria, Research Support
Merck Advisory Board, Consultant, Honoraria, Research Support
Pfizer Consultant, Honoraria, Research Support
Scynexis
Consultant
Viamet Consultant

* Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top